Alberto Martini, Lieke Wever, Timo F W Soeterik, Arnas Rakauskas, Christian Daniel Fankhauser, Josias Bastian Grogg, Enrico Checcucci, Daniele Amparore, Luciano Haiquel, Lara Rodriguez-Sanchez, Guillaume Ploussard, Peng Qiang, Andres Affentranger, Alessandro Marquis, Giancarlo Marra, Otto Ettala, Fabio Zattoni, Ugo Giovanni Falagario, Mario De Angelis, Claudia Kesch, Maria Apfelbeck, Tarek Al-Hammouri, Alexander Kretschmer, Veeru Kasivisvanathan, Felix Preisser, Emilie Lefebvre, Jonathan Olivier, Jan Philipp Radtke, Alberto Briganti, Francesco Montorsi, Giuseppe Carrieri, Fabrizio Dal Moro, Peter Boström, Ivan Jambor, Paolo Gontero, Peter K Chiu, Hubert John, Petr Macek, Francesco Porpiglia, Thomas Hermanns, Roderick C N van den Bergh, Jean-Paul A van Basten, Giorgio Gandaglia, Massimo Valerio
PURPOSE: Bilateral extended pelvic lymph node dissection at the time of radical prostatectomy is the current standard of care if pelvic lymph node dissection is indicated; often, however, pelvic lymph node dissection is performed in pN0 disease. With the more accurate staging achieved with magnetic resonance imaging-targeted biopsies for prostate cancer diagnosis, the indication for bilateral extended pelvic lymph node dissection may be revised . We aimed to assess the feasibility of unilateral extended pelvic lymph node dissection in the era of modern prostate cancer imaging...
July 2023: Journal of Urology